Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-021806
Filing Date
2021-06-03
Accepted
2021-06-03 16:41:47
Documents
2
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1565
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4762
  Complete submission text file 0000899243-21-021806.txt   7732
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Issuer) CIK: 0001656536 (see all company filings)

EIN.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 1520 NEW YORK NY 10016
Business Address
Carson William H. (Reporting) CIK: 0001824280 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40030 | Film No.: 21993092